TREATMENT OF ENTERAL FEEDING INTOLERANCE AND MUSCLE WASTING

摘要

Enteral feeding intolerance and conditions associated with loss of muscle mass can be efficaciously treated by administration of therapeutically effective doses of ulimorelin every 8 hours (three times a day). Ulimorelin is administered to: intensive care unit patients; intensive care unit patients with enteral feeding intolerance; patients requiring an increase in muscle mass, slowing the rate of muscle loss, or treating diseases associated with muscle loss; and populations of intensive care unit patients. Other features of the invention include dosing concentrations and schedules, methods of diagnosing and monitoring patients and specific patient populations.